BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34881093)

  • 1. A Next-Generation Vaccine Candidate Using Alternative Epitopes to Protect against Wuhan and All Significant Mutant Variants of SARS-CoV-2: An Immunoinformatics Approach.
    Bhattacharya M; Sharma AR; Ghosh P; Lee SS; Chakraborty C
    Aging Dis; 2021 Dec; 12(8):2173-2195. PubMed ID: 34881093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
    Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough.
    Bhattacharya M; Alshammari A; Alharbi M; Dhama K; Lee SS; Chakraborty C
    Int J Biol Macromol; 2023 Jul; 242(Pt 2):124893. PubMed ID: 37207746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest.
    Saba AA; Adiba M; Saha P; Hosen MI; Chakraborty S; Nabi AHMN
    Comput Biol Med; 2021 Sep; 136():104703. PubMed ID: 34352457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
    Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
    J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing a Multi-epitope Vaccine against the SARS-CoV-2 Variant based on an Immunoinformatics Approach.
    Farhani I; Yamchi A; Madanchi H; Khazaei V; Behrouzikhah M; Abbasi H; Salehi M; Moradi N; Sanami S
    Curr Comput Aided Drug Des; 2024; 20(3):274-290. PubMed ID: 37309762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Almofti YA; Abd-Elrahman KA; Eltilib EEM
    BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches.
    Aasim ; Sharma R; Patil CR; Kumar A; Sharma K
    In Silico Pharmacol; 2022; 10(1):12. PubMed ID: 35898574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants.
    Ezzemani W; Kettani A; Sappati S; Kondaka K; El Ossmani H; Tsukiyama-Kohara K; Altawalah H; Saile R; Kohara M; Benjelloun S; Ezzikouri S
    J Biomol Struct Dyn; 2023 Jul; 41(11):4917-4938. PubMed ID: 35549819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
    Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
    J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern.
    Al-Fattah Yahaya AA; Khalid K; Lim HX; Poh CL
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2.
    Kumar KM; Karthik Y; Ramakrishna D; Balaji S; Skariyachan S; Murthy TPK; Sakthivel KM; Alotaibi BS; Shukry M; Sayed SM; Mushtaq M
    Front Microbiol; 2023; 14():1251716. PubMed ID: 37915849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
    Jyotisha ; Singh S; Qureshi IA
    J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex.
    Bhattacharya M; Sharma AR; Mallick B; Sharma G; Lee SS; Chakraborty C
    Infect Genet Evol; 2020 Nov; 85():104587. PubMed ID: 33039603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
    Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
    Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
    Jain N; Shankar U; Majee P; Kumar A
    Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.
    Yu M; Zhu Y; Li Y; Chen Z; Li Z; Wang J; Li Z; Zhang F; Ding J
    Front Immunol; 2022; 13():884433. PubMed ID: 35603198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.